Evaluation of Inflammatory Response System (IRS) and Compensatory Immune Response System (CIRS) in Adolescent Major Depression
Nikola Ferencova,Zuzana Visnovcova,Igor Ondrejka,Dana Funakova,Igor Hrtanek,Simona Kelcikova,Ingrid Tonhajzerova
DOI: https://doi.org/10.2147/JIR.S387588
IF: 4.5
2022-10-26
Journal of Inflammation Research
Abstract:Nikola Ferencova, 1 Zuzana Visnovcova, 1 Igor Ondrejka, 2 Dana Funakova, 2 Igor Hrtanek, 2 Simona Kelcikova, 3 Ingrid Tonhajzerova 4 1 Biomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovak Republic; 2 Psychiatric Clinic, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Hospital Martin, Martin, Slovak Republic; 3 Department of Midwifery, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovak Republic; 4 Department of Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovak Republic Correspondence: Ingrid Tonhajzerova, Department of Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4C, Martin, Slovak Republic, Tel +421432633425, Email Purpose: Nowadays, the role of two tightly interconnected systems, the inflammatory response system (IRS) and the compensatory immune response system (CIRS) in depression, is increasingly discussed. Various studies indicate pro-inflammatory activity in adolescent depression; however, there is an almost complete lack of findings about IRS and CIRS balance. Thus, we aimed to assess different IRS and CIRS indices, profiles, and IRS/CIRS ratios in drug-naïve MDD patients at adolescent age, with respect to sex. Patients and Methods: One hundred MDD adolescents (40 boys, average age: 15.4± 1.2 yrs.) and 60 controls (28 boys, average age: 15.3± 1.5 yrs.) were examined. Evaluated parameters were 1. plasma levels of interleukin (IL)-1α, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, interferon gamma, tumor necrosis factor alpha (TNF-α), soluble receptor of IL-6 (sIL-6R), soluble receptors of TNF-α (sTNF-R1, sTNF-R2); 2. profiles: IL-6 trans-signaling, M1 macrophage signaling, helper T lymphocytes (Th) 1 profile, regulatory T lymphocytes (Treg)+Th2, allIRS, and allCIRS; 3. IRS vs CIRS activity ratios: TNF-α/TNF-R1, TNF-α/TNF-R2, TNF-α/sTNF-Rs (ie sTNF-R1+sTNF-R2), Th1/Th2, Th1/Treg, Th1/Th2+Treg, M1/Th2, M1/Treg, M1/Treg+Th2, allIRS/allCIRS. Results: MDD patients showed increased IL-4, IL-10, TNF-α, sIL-6R, Treg+Th2, allIRS, allCIRS, and TNF-α/sTNF-Rs, and decreased Th1/Th2+Treg. MDD females showed increased IL-10 and TNF-α compared to control females. MDD males showed increased IL-4, IL-10, sIL-6R, Treg+Th2, and TNF-α/TNF-R1 compared to control males. Increased sTNF-R1 was found in MDD males compared to MDD females. Positive correlations were found between CDI score and sIL-6R and IL-10 in the total group and between CDI score and IL-10 in adolescent males. Conclusion: Our study for the first time extensively evaluated IRS and CIRS interactions revealing enhanced pro-inflammatory TNF-α signaling and IL-6 trans-signaling in association with increased IL-10- and IL-4-mediated anti-inflammatory activity in first-episode depression at the adolescent age. Moreover, results reflect the sex-specific simultaneous activation of IRS and CIRS pathways in adolescent depression. Keywords: major depressive disorder, adolescent age, comprehensive cytokine analysis, neuroimmune interactions, sex differences Major depressive disorder (MDD) represents a common mood disorder affecting approximately 300 million people worldwide 1 with increasing incidence, particularly at adolescent age. 2,3 Moreover, MDD is the largest mental health contributor to the disease burden in adolescents. 4 However, the response rates to the psycho- and pharmaco-therapy in adolescent depression are only modest, 5 thus a better understanding of the underlying pathophysiological mechanisms in MDD can contribute to personalized assessment and treatment of depression. Although various risk factors and etiological models in depression have been proposed, in the last few decades, the role of immune dysregulation as one of the most robust mechanisms contributing to MDD pathophysiology has been increasingly discussed. 6,7 The presence of the inflammatory process in depressive patients can be easily revealed by complete blood cells count reflecting cell blood composition including red blood cells (RBC), RBC distribution width (RDW), platelets, mean platelet volume, and white blood cells (WBC) with differential (eg neutrophils and lymphocytes) as one of the most widespread and frequently used laboratory tests in the clinical setting. More specifically, increased WBC as indicators of the overall immune system activity associated with neutrophilia have been repeatedly reported in adult and adolescent depressive patients compared to controls. 8–11 Further, measures of com -Abstract Truncated-
immunology